Clinical Trials Directory

Trials / Completed

CompletedNCT03090360

Growth of Infants Fed a New Term Infant Formula

Growth of Infants Fed a New Term Infant Formula With a Prebiotic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
349 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
14 Days
Healthy volunteers
Accepted

Summary

To evaluate the growth of healthy term infants fed an experimental infant formula with a prebiotic, a commercial control infant formula with a probiotic, but without a prebiotic and human breast milk

Detailed description

Multisite, double-blind, randomized, controlled clinical trial. The purpose of the study is to determine if infants fed a standard infant formula with a prebiotic have a weight gain in line with infants fed a standard starter infant formula without a prebiotic.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInfant formula (CF)Formula-fed infants will be randomly assigned to receive one of the study formulas (CF or EF) orally, ad libitum, each day from Study Day 1 until Study Day 180, for a treatment duration of approximately 180 days.
DIETARY_SUPPLEMENTInfant Formula (EF)Formula-fed infants will be randomly assigned to receive one of the study formulas (CF or EF) orally, ad libitum, each day from Study Day 1 until Study Day 180, for a treatment duration of approximately 180 days.

Timeline

Start date
2017-02-21
Primary completion
2019-04-11
Completion
2019-05-21
First posted
2017-03-24
Last updated
2019-07-05

Locations

7 sites across 2 countries: Belgium, Italy

Source: ClinicalTrials.gov record NCT03090360. Inclusion in this directory is not an endorsement.

Growth of Infants Fed a New Term Infant Formula (NCT03090360) · Clinical Trials Directory